🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carlos Caulı́n

University of Arizona

ORCID: 0000-0002-5059-0016

Also affiliated with Arizona Oncology, University of Arizona Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC)..

7 citations

Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia +14 more

0 citations

Tongxin Xie, Thomas J. Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou +6 more

0 citations

Tongxin Xie, Thomas J. Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou +6 more

Impact of AIM2 on HNSCC Development

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.27.615454
N/A
0DataRank · unranked
2 citations

Vicente Escamilla-River, Stephanie L Tribble, Carlos Caulı́n, Justin E. Wilson, Dakota M. Reinartz

1 citations

Vicente Escamilla‐Rivera, Manlin Shao, Stephanie L Tribble, Carlos Caulı́n, Justin E. Wilson +1 more